Literature DB >> 22405509

Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy.

Ashutosh Tewari1, Prasanna Sooriakumaran, Daniel A Bloch, Usha Seshadri-Kreaden, April E Hebert, Peter Wiklund.   

Abstract

CONTEXT: Radical prostatectomy (RP) approaches have rarely been compared adequately with regard to margin and perioperative complication rates.
OBJECTIVE: Review the literature from 2002 to 2010 and compare margin and perioperative complication rates for open retropubic RP (ORP), laparoscopic RP (LRP), and robot-assisted LRP (RALP). EVIDENCE ACQUISITION: Summary data were abstracted from 400 original research articles representing 167,184 ORP, 57,303 LRP, and 62,389 RALP patients (total: 286,876). Articles were found through PubMed and Scopus searches and met a priori inclusion criteria (eg, surgery after 1990, reporting margin rates and/or perioperative complications, study size>25 cases). The primary outcomes were positive surgical margin (PSM) rates, as well as total intra- and perioperative complication rates. Secondary outcomes included blood loss, transfusions, conversions, length of hospital stay, and rates for specific individual complications. Weighted averages were compared for each outcome using propensity adjustment. EVIDENCE SYNTHESIS: After propensity adjustment, the LRP group had higher positive surgical margin rates than the RALP group but similar rates to the ORP group. LRP and RALP showed significantly lower blood loss and transfusions, and a shorter length of hospital stay than the ORP group. Total perioperative complication rates were higher for ORP and LRP than for RALP. Total intraoperative complication rates were low for all modalities but lowest for RALP. Rates for readmission, reoperation, nerve, ureteral, and rectal injury, deep vein thrombosis, pneumonia, hematoma, lymphocele, anastomotic leak, fistula, and wound infection showed significant differences between groups, generally favoring RALP. The lack of randomized controlled trials, use of margin status as an indicator of oncologic control, and inability to perform cost comparisons are limitations of this study.
CONCLUSIONS: This meta-analysis demonstrates that RALP is at least equivalent to ORP or LRP in terms of margin rates and suggests that RALP provides certain advantages, especially regarding decreased adverse events.
Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22405509     DOI: 10.1016/j.eururo.2012.02.029

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  115 in total

1.  Urological cancer: For localized prostate cancer, does technology equal progress?

Authors:  Matthew R Cooperberg
Journal:  Nat Rev Clin Oncol       Date:  2012-06-05       Impact factor: 66.675

2.  Prostate cancer: a new look at prostate cancer treatment complications.

Authors:  Matthew R Cooperberg
Journal:  Nat Rev Clin Oncol       Date:  2014-04-01       Impact factor: 66.675

3.  Comparison of oncological outcomes between retropubic radical prostatectomy and robot-assisted radical prostatectomy: an analysis stratified by surgical experience.

Authors:  Jinsung Park; Dae-Seon Yoo; Cheryn Song; Sahyun Park; Sejun Park; Seong Cheol Kim; Yongmee Cho; Hanjong Ahn
Journal:  World J Urol       Date:  2013-09-24       Impact factor: 4.226

4.  Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.

Authors:  Michael S Leapman; Stephen J Freedland; William J Aronson; Christopher J Kane; Martha K Terris; Kelly Walker; Christopher L Amling; Peter R Carroll; Matthew R Cooperberg
Journal:  J Urol       Date:  2016-06-25       Impact factor: 7.450

Review 5.  Avoiding and managing vascular injury during robotic-assisted radical prostatectomy.

Authors:  René Sotelo; Luciano A Nunez Bragayrac; Victor Machuca; Roberto Garza Cortes; Raed A Azhar
Journal:  Ther Adv Urol       Date:  2015-02

6.  No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer.

Authors:  K Boehm; B Beyer; P Tennstedt; J Schiffmann; L Budaeus; A Haese; M Graefen; T Schlomm; H Heinzer; G Salomon
Journal:  World J Urol       Date:  2014-07-03       Impact factor: 4.226

7.  Intraoperative laparoscopic complications for urological cancer procedures.

Authors:  Sergio Fernández-Pello Montes; Ivan Gonzalez Rodríguez; Rodrigo Gil Ugarteburu; Luis Rodríguez Villamil; Begoña Diaz Mendez; Patricio Suarez Gil; Javier Mosquera Madera
Journal:  World J Clin Cases       Date:  2015-05-16       Impact factor: 1.337

8.  Intraoperative frozen section monitoring during nerve-sparing radical prostatectomy: evaluation of partial secondary resection of neurovascular bundles and its effect on oncologic and functional outcome.

Authors:  Georgios Hatzichristodoulou; Stefan Wagenpfeil; Gregor Weirich; Michael Autenrieth; Tobias Maurer; Mark Thalgott; Thomas Horn; Matthias Heck; Kathleen Herkommer; Jürgen E Gschwend; Hubert Kübler
Journal:  World J Urol       Date:  2015-06-23       Impact factor: 4.226

Review 9.  Recent advances in robotic surgery for rectal cancer.

Authors:  Soichiro Ishihara; Kensuke Otani; Koji Yasuda; Takeshi Nishikawa; Junichiro Tanaka; Toshiaki Tanaka; Tomomichi Kiyomatsu; Keisuke Hata; Kazushige Kawai; Hiroaki Nozawa; Shinsuke Kazama; Hironori Yamaguchi; Eiji Sunami; Joji Kitayama; Toshiaki Watanabe
Journal:  Int J Clin Oncol       Date:  2015-06-10       Impact factor: 3.402

10.  Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.

Authors:  J L Donovan; F C Hamdy; J A Lane; D E Neal; M Mason; C Metcalfe; E Walsh; J M Blazeby; T J Peters; P Holding; S Bonnington; T Lennon; L Bradshaw; D Cooper; P Herbert; J Howson; A Jones; N Lyons; E Salter; P Thompson; S Tidball; J Blaikie; C Gray; P Bollina; J Catto; A Doble; A Doherty; D Gillatt; R Kockelbergh; H Kynaston; A Paul; P Powell; S Prescott; D J Rosario; E Rowe; M Davis; E L Turner; R M Martin
Journal:  N Engl J Med       Date:  2016-09-14       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.